Free tool
FAERS Monitor: Carnitor
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018948 or its brand name (Carnitor, Levocarnitine). Reports on generic versions are filed under their own applications.
Reports
3,646
Serious
2,818
77% of reports
Hospitalization
1,713
Death reported
395
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure391
- off label use309
- vomiting230
- diarrhoea210
- drug ineffective195
- fatigue185
- pneumonia182
- pyrexia174
- nausea135
- product dose omission issue133
- somnolence131
- decreased appetite123
- death120
- dyspnoea106
- headache92
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 23 |
| 2005 | 17 |
| 2006 | 12 |
| 2007 | 28 |
| 2008 | 53 |
| 2009 | 32 |
| 2010 | 30 |
| 2011 | 34 |
| 2012 | 57 |
| 2013 | 71 |
| 2014 | 80 |
| 2015 | 124 |
| 2016 | 226 |
| 2017 | 159 |
| 2018 | 195 |
| 2019 | 228 |
| 2020 | 271 |
| 2021 | 255 |
| 2022 | 356 |
| 2023 | 411 |
| 2024 | 408 |
| 2025 | 353 |
| 2026 | 223 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,513 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 391 | 19.6 | 17.8 | 6,894 |
| somnolenceSignal | 131 | 3.8 | 3.2 | 264 |
| pneumoniaSignal | 182 | 3.2 | 2.8 | 285 |
| decreased appetiteSignal | 123 | 3.1 | 2.6 | 170 |
| pyrexiaSignal | 174 | 2.9 | 2.5 | 218 |
| vomitingSignal | 230 | 2.8 | 2.5 | 275 |
| product dose omission issueSignal | 133 | 2.6 | 2.2 | 132 |
| off label useSignal | 309 | 2.0 | 1.8 | 169 |
| diarrhoea | 210 | 1.9 | 1.6 | 88 |
| fatigue | 185 | 1.4 | 1.2 | 19 |
| dyspnoea | 106 | 1.1 | 0.9 | 1 |
| nausea | 135 | 1.0 | 0.8 | 0 |
| drug ineffective | 195 | 0.9 | 0.7 | 5 |
| headache | 92 | 0.8 | 0.7 | 2 |
| death | 120 | 0.8 | 0.7 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.